Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Whiting, CC"'
Autor:
Liu, SD, Whiting, CC, Tomassian, T, Pang, M, Bissel, SJ, Baum, LG, Mossine, VV, Poirier, F, Huflejt, ME, Miceli, MC
Publikováno v:
BLOOD, vol 112, iss 1
Liu, SD; Whiting, CC; Tomassian, T; Pang, M; Bissel, SJ; Baum, LG; et al.(2008). Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes. BLOOD, 112(1), 120-130. doi: 10.1182/blood-2007-09-114181. UCLA: Retrieved from: http://www.escholarship.org/uc/item/8ff7r66s
Liu, SD; Whiting, CC; Tomassian, T; Pang, M; Bissel, SJ; Baum, LG; et al.(2008). Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes. BLOOD, 112(1), 120-130. doi: 10.1182/blood-2007-09-114181. UCLA: Retrieved from: http://www.escholarship.org/uc/item/8ff7r66s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::db6630b90c6643d2ef2b3b772579b4d6
https://escholarship.org/uc/item/8ff7r66s
https://escholarship.org/uc/item/8ff7r66s
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Whiting CC
Publikováno v:
Physical & Occupational Therapy in Pediatrics; 2002, Vol. 22 Issue 1, p81-89, 9p
Autor:
Yarchoan M; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Powderly JD; Carolina BioOncology Institute, Huntersville, North Carolina., Bastos BR; Baptist Health Miami Cancer Institute, Miami, Florida., Karasic TB; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania., Crysler OV; University of Michigan Rogel Cancer Center, Ann Arbor, Michigan., Munster PN; UCSF Health - UCSF Medical Center, San Francisco, California., McKean MA; Sarah Cannon Research Institute, Nashville, Tennessee., Emens LA; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Saenger YM; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York., Ged Y; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland., Stagg R; Tempest Therapeutics, Brisbane, California., Smith S; Tempest Therapeutics, Brisbane, California., Whiting CC; Tempest Therapeutics, Brisbane, California., Moon A; Tempest Therapeutics, Brisbane, California., Prasit P; Tempest Therapeutics, Brisbane, California., Jenkins Y; Tempest Therapeutics, Brisbane, California., Standifer N; Tempest Therapeutics, Brisbane, California., Dubensky TW; Tempest Therapeutics, Brisbane, California., Whiting SH; Tempest Therapeutics, Brisbane, California., Ulahannan SV; Stephenson Cancer Center of the University of Oklahoma/Sarah Cannon Research Institute, Oklahoma City, Oklahoma.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Apr 18; Vol. 4 (4), pp. 1100-1110.
Autor:
Francica BJ; Tempest Therapeutics, Brisbane, California., Holtz A; Tempest Therapeutics, Brisbane, California., Lopez J; Tempest Therapeutics, Brisbane, California., Freund D; Tempest Therapeutics, Brisbane, California., Chen A; Tempest Therapeutics, Brisbane, California., Wang D; Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina., Powell D; Tempest Therapeutics, Brisbane, California., Kipper F; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Panigrahy D; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts., Dubois RN; Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina., Whiting CC; Tempest Therapeutics, Brisbane, California., Prasit P; Tempest Therapeutics, Brisbane, California., Dubensky TW; Tempest Therapeutics, Brisbane, California.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2023 Aug 08; Vol. 3 (8), pp. 1486-1500. Date of Electronic Publication: 2023 Aug 08 (Print Publication: 2023).
Autor:
Whiting CC; Colleen Cameron Whiting, OTD, OTR/L, is Lecturer, Department of Occupational Therapy Online Program, Boston University, Boston, MA; whitingcolleen@gmail.com., Schoen SA; Sarah A. Schoen, PhD, OTR, is Director of Research, STAR Institute, Centennial, CO., Niemeyer L; Linda Niemeyer, PhD, OT, is Lecturer, Department of Occupational Therapy Online Program, Boston University, Boston, MA.
Publikováno v:
The American journal of occupational therapy : official publication of the American Occupational Therapy Association [Am J Occup Ther] 2023 Mar 01; Vol. 77 (2).
Autor:
Hassan R; Thoracic and GI Malignancies Branch, National Cancer Institute, Bethesda, Maryland. hassanr@mail.nih.gov., Alley E; Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Kindler H; Gastrointestinal Oncology and Mesothelioma Programs, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois., Antonia S; Thoracic Oncology Department, Moffitt Cancer Center, Tampa, Florida., Jahan T; Department of Medicine, Division of Hematology Oncology, University of California, San Francisco, San Francisco, California., Honarmand S; Aduro Biotech, Inc., Berkeley, California., Nair N; Aduro Biotech, Inc., Berkeley, California., Whiting CC; Aduro Biotech, Inc., Berkeley, California., Enstrom A; Aduro Biotech, Inc., Berkeley, California., Lemmens E; Aduro Biotech, Inc., Berkeley, California., Tsujikawa T; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Kumar S; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Choe G; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Thomas A; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, Maryland., McDougall K; Aduro Biotech, Inc., Berkeley, California., Murphy AL; Aduro Biotech, Inc., Berkeley, California., Jaffee E; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland., Coussens LM; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Brockstedt DG; Aduro Biotech, Inc., Berkeley, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Oct 01; Vol. 25 (19), pp. 5787-5798. Date of Electronic Publication: 2019 Jul 01.
Autor:
Richards S; Sanofi, Framingham, MA, USA., Amaravadi L; Sanofi, Framingham, MA, USA., Pillutla R; Bristol-Myers Squibb, Princeton, NJ, USA., Birnboeck H; Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland., Torri A; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Cowan KJ; Genentech, South San Francisco, CA, USA., Papadimitriou A; Roche Pharma Research and Early Development, Roche Innovation Center, Munich, Germany., Garofolo F; Angelini Pharma, Pomezia, RM, Italy., Satterwhite C; Charles River, Reno, NV, USA., Piccoli S; Bristol-Myers Squibb, Princeton, NJ, USA., Wu B; Janssen R&D, Spring House, PA, USA., Krinos-Fiorotti C; Bioagilytix Labs, Durham, NC, USA., Allinson J; LGC, Cambridge, UK., Berisha F; Daiichi Sankyo, Edison, NJ, USA., Cocea L; Health Canada, Ottawa, ON, Canada., Croft S; WHO, Geneva, Switzerland., Fraser S; Pfizer, Groton, CT, USA., Galliccia F; Italy AIFA, Rome, Italy., Gorovits B; Pfizer, Andover, MA, USA., Gupta S; Allergan, Irvine, CA, USA., Gupta V; Genentech, South San Francisco, CA, USA., Haidar S; US FDA, Silver Spring, MD, USA., Hottenstein C; GlaxoSmithKline, Paoli, PA, USA., Ishii-Watabe A; Japan MHLW-NIHS, Tokyo, Japan., Jani D; Pfizer, Andover, MA, USA., Kadavil J; US FDA, Silver Spring, MD, USA., Kamerud J; Eurofins Bioanalytical Services, St Charles, MO, USA., Kramer D; Sanofi, Frankfurt am Main, Germany., Litwin V; Covance, Indianapolis, IN, USA., Lima Santos GM; Brazil Anvisa, Brasilia, Brazil., Nelson R; Novimmune, Geneva, Switzerland., Ni Y; Bristol-Myers Squibb, Princeton, NJ, USA., Pedras-Vasconcelos J; US FDA, Silver Spring, MD, USA., Qiu Y; Shire, Lexington, MA, USA., Rhyne P; Q2 Solutions, Marietta, GA, USA., Safavi A; Bioagilytix Labs, Durham, NC, USA., Saito Y; Japan MHLW-NIHS, Tokyo, Japan., Savoie N; CFABS, Laval, QC, Canada., Scheibner K; US FDA, Silver Spring, MD, USA., Schick E; Roche Pharma Research and Early Development, Roche Innovation Center, Basel, Switzerland., Siguenza PY; Genentech, South San Francisco, CA, USA., Smeraglia J; UCB Biopharma, Braine L'Alleud, Belgium., Staack RF; Roche Pharma Research and Early Development, Roche Innovation Center, Munich, Germany., Subramanyam M; Biogen, Cambridge, MA, USA., Sumner G; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Thway T; Amgen, Thousand Oaks, CA, USA., Uhlinger D; Janssen R&D, Spring House, PA, USA., Ullmann M; EMD Serono, Aubonne, Switzerland., Vitaliti A; Novartis Pharma, Basel, Switzerland., Welink J; Dutch MEB, Utrecht, The Netherlands., Whiting CC; Aduro Biotech, Berkeley, CA, USA., Xue L; Pfizer, Andover, MA, USA., Zeng R; OncoMed Pharmaceuticals, Redwood City, CA, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2016 Dec; Vol. 8 (23), pp. 2475-2496.
Autor:
Whiting CC; Institute for Immunity, Transplantation, and Infection, Stanford School of Medicine, Stanford University, Stanford, CA, United States of America; Division of Rheumatology and Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America., Siebert J; CytoAnalytics, Denver, CO, United States of America., Newman AM; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America., Du HW; Institute for Immunity, Transplantation, and Infection, Stanford School of Medicine, Stanford University, Stanford, CA, United States of America; Division of Rheumatology and Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America., Alizadeh AA; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America., Goronzy J; Division of Rheumatology and Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America., Weyand CM; Division of Rheumatology and Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America., Krishnan E; Division of Rheumatology and Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America., Fathman CG; Institute for Immunity, Transplantation, and Infection, Stanford School of Medicine, Stanford University, Stanford, CA, United States of America; Division of Rheumatology and Immunology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America., Maecker HT; Institute for Immunity, Transplantation, and Infection, Stanford School of Medicine, Stanford University, Stanford, CA, United States of America.
Publikováno v:
PloS one [PLoS One] 2015 Jul 21; Vol. 10 (7), pp. e0133627. Date of Electronic Publication: 2015 Jul 21 (Print Publication: 2015).
Autor:
Nair N; Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. nnair@aduro.com.; Division of Immune Monitoring and Biomarker Development, Aduro BioTech, Inc., Berkeley, CA, 94710, USA. nnair@aduro.com.; Department of Medicine, Stanford University, Stanford, CA, 94305, USA. nnair@aduro.com., Mei HE; Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, 94305, USA. hemei@stanford.edu., Chen SY; Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. siychen@stanford.edu., Hale M; Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. mhale@stanford.edu., Nolan GP; Department of Microbiology and Immunology, Stanford University, Stanford, CA, 94305, USA. gnolan@stanford.edu., Maecker HT; Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA, 94305, USA. maecker@stanford.edu., Genovese M; Department of Medicine, Stanford University, Stanford, CA, 94305, USA. genovese@stanford.edu., Fathman CG; Department of Medicine, Stanford University, Stanford, CA, 94305, USA. cfathman@stanford.edu., Whiting CC; Division of Immune Monitoring and Biomarker Development, Aduro BioTech, Inc., Berkeley, CA, 94710, USA. cwhiting@aduro.com.; Department of Medicine, Stanford University, Stanford, CA, 94305, USA. cwhiting@aduro.com.
Publikováno v:
Arthritis research & therapy [Arthritis Res Ther] 2015 May 18; Vol. 17, pp. 127. Date of Electronic Publication: 2015 May 18.